These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33006767)

  • 1. Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Thomas KS; Batchelor JM; Akram P; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Sach TH; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell NJ; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):828-839. PubMed ID: 33006767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
    Sach TH; Thomas KS; Batchelor JM; Perways A; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell N; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):840-848. PubMed ID: 32920824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial.
    Haines RH; Thomas KS; Montgomery AA; Ravenscroft JC; Akram P; Chalmers JR; Whitham D; Duley L; Eleftheriadou V; Meakin G; Mitchell EJ; White J; Rogers A; Sach T; Santer M; Tan W; Hepburn T; Williams HC; Batchelor J
    BMJ Open; 2018 Apr; 8(4):e018649. PubMed ID: 29615444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy).
    Eleftheriadou V; Thomas K; Ravenscroft J; Whitton M; Batchelor J; Williams H
    Trials; 2014 Feb; 15():51. PubMed ID: 24507484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
    Khullar G; Kanwar AJ; Singh S; Parsad D
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
    Bakis-Petsoglou S; Le Guay JL; Wittal R
    Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
    Nordal EJ; Guleng GE; Rönnevig JR
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo.
    Akdeniz N; Yavuz IH; Gunes Bilgili S; Ozaydın Yavuz G; Calka O
    J Dermatolog Treat; 2014 Jun; 25(3):196-9. PubMed ID: 23441902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
    Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
    Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
    J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study.
    Khemis A; Fontas E; Moulin S; Montaudié H; Lacour JP; Passeron T
    J Invest Dermatol; 2020 Aug; 140(8):1533-1537.e2. PubMed ID: 32004567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.